Cell Therapy News/Articles, page-10497

@ImaScientist

Here you go:

	< 65 mITT # patients	Remestemcel-L	Controls	Totals
	Dexamethasone	29	44	73
	No Dexamethasone	28	22	50
	Combined under 65 mITT	57	66	123

	< 65 mITT #deaths through day 90	Remestemcel-L	Controls	Totals
	Dexamethasone	4	21	25
	No Dexamethasone	11	8	19
	Combined under 65 mITT	15	29	44

	< 65 mITT 90 day mortality %	Remestemcel-L	Controls	Totals
	Dexamethasone	13.8%	47.7%	34.2%
	No Dexamethasone	39.3%	36.4%	38.0%
	Combined under 65 mITT	26.3%	43.9%	35.8%

	< 65 mITT 90 day survival	Remestemcel-L	Controls	Totals
	Dexamethasone	86.2%	52.3%	65.8%
	No Dexamethasone	60.7%	63.6%	62.0%
	Combined under 65 mITT	73.7%	56.1%	64.2%